These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18701831)

  • 1. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study.
    Salminen JK; Karlsson H; Hietala J; Kajander J; Aalto S; Markkula J; Rasi-Hakala H; Toikka T
    Psychother Psychosom; 2008; 77(6):351-7. PubMed ID: 18701831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does defense style or psychological mindedness predict treatement response in major depression?
    Kronström K; Salminen JK; Hietala J; Kajander J; Vahlberg T; Markkula J; Rasi-Hakala H; Karlsson H
    Depress Anxiety; 2009; 26(7):689-95. PubMed ID: 19496102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy.
    Bellino S; Zizza M; Rinaldi C; Bogetto F
    Can J Psychiatry; 2007 Nov; 52(11):718-25. PubMed ID: 18399039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design.
    Menchetti M; Bortolotti B; Rucci P; Scocco P; Bombi A; Berardi D;
    BMC Psychiatry; 2010 Nov; 10():97. PubMed ID: 21108824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
    Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
    Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
    Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
    Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants.
    O'Reardon JP; Chopra MP; Bergan A; Gallop R; DeRubeis RJ; Crits-Christoph P
    Biol Psychiatry; 2004 May; 55(9):957-9. PubMed ID: 15110741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of brief interpersonal psychotherapy for depression among women.
    Swartz HA; Frank E; Shear MK; Thase ME; Fleming MA; Scott J
    Psychiatr Serv; 2004 Apr; 55(4):448-50. PubMed ID: 15067162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-effect relations in time-limited combined psycho-pharmacological treatment for depression.
    Dekker J; Molenaar PJ; Kool S; Van Aalst G; Peen J; de Jonghe F
    Psychol Med; 2005 Jan; 35(1):47-58. PubMed ID: 15842028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive changes in depressed patients in psychodynamic psychotherapy, therapy with fluoxetine and combination therapy.
    Bastos AG; Guimarães LS; Trentini CM
    J Affect Disord; 2013 Dec; 151(3):1066-75. PubMed ID: 24103853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.
    Akhondzadeh S; Jafari S; Raisi F; Nasehi AA; Ghoreishi A; Salehi B; Mohebbi-Rasa S; Raznahan M; Kamalipour A
    Depress Anxiety; 2009; 26(7):607-11. PubMed ID: 19496103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.
    Lin CH; Lin KS; Lin CY; Chen MC; Lane HY
    J Clin Psychiatry; 2008 Jan; 69(1):54-9. PubMed ID: 18312038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.
    Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC;
    JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.
    Ninan PT; Hassman HA; Glass SJ; McManus FC
    J Clin Psychiatry; 2004 Mar; 65(3):414-20. PubMed ID: 15096082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.
    Jazayeri S; Tehrani-Doost M; Keshavarz SA; Hosseini M; Djazayery A; Amini H; Jalali M; Peet M
    Aust N Z J Psychiatry; 2008 Mar; 42(3):192-8. PubMed ID: 18247193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
    Vitiello B; Rohde P; Silva S; Wells K; Casat C; Waslick B; Simons A; Reinecke M; Weller E; Kratochvil C; Walkup J; Pathak S; Robins M; March J;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1419-26. PubMed ID: 17135987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up.
    Knekt P; Lindfors O; Härkänen T; Välikoski M; Virtala E; Laaksonen MA; Marttunen M; Kaipainen M; Renlund C;
    Psychol Med; 2008 May; 38(5):689-703. PubMed ID: 18005493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing effects of citalopram with fluoxetine on sleep quality in patients with major depressive disorder.
    Shahsavand-Ananloo E; Berenji F; Sadeghniiat K; Alimadadi A; Zahiroddin AR; Tabatabaee M; Abbasi-Asl M; Ghaeli P
    Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1155-61. PubMed ID: 23690183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.